Long-term Outcomes of May-Thurner Syndrome in Pediatric Patients

Overview

About this study

The purpose of this study is to analyze thrombosis outcomes among pediatric patients with May-Thurner Syndrome who received stents or no vascular stents.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients 21 years of age or younger with confirmed diagnosis of May-Thurner Syndrome.

Exclusion Criteria:

  • Patients with DVT not associated with May-Thurner Syndrome anatomic variant.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Vilmarie Rodriguez, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20306915

Mayo Clinic Footer